Sanofi Pasteur prepares to market profitable vaccine against dengue.

After 20 years of research and development on a vaccine against the mosquito-borne viral disease known as dengue, pharmaceutical firm Sanofi Pasteur SA of France has now produced a vaccine it believes will be both effective and extremely profitable, according to The Financial Times. In a recent article, the newspaper quoted Sanofi Pasteur’s chief executive, Olivier Charmeil, as saying, “The dengue vaccine will be in the high end of profitability among our vaccines.” The newspaper reports:

Read full story here: Sanofi Pasteur prepares to market profitable vaccine against dengue.

Please follow and like us:

Related Post

Leave a Reply